# Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line.

> PubMed lists PMID 39561351 in Diabetes as Journal Article, with publication-date metadata of 2025-02-01 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39561351-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-21
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39561351-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39561351-glucagon-v1.json
- Content SHA-256: `9a8c5b98394ffa36aa8f2137c8c53296b19844a254b6f24ef8a24d5f34482cf6`

## Claims and source pins

### Headline

Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line. ([`pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641`](#source-pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641))

### Summary

PubMed lists PMID 39561351 in Diabetes as Journal Article, with publication-date metadata of 2025-02-01 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641`](#source-pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641))

### Paragraph 1

PubMed lists PMID 39561351 in Diabetes as Journal Article, with publication-date metadata of 2025-02-01 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641`](#source-pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641`](#source-pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641))

## Sources

<a id="source-pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641"></a>
- **Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line. · retained source version 1:2026-07-21:current:66ee4756e64197c37a394d38dd296f995b401df90686fbe738c0fb2d4acd8c5d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39561351/) (`pubmed-observation-pmid-39561351-2026-07-21-66ee4756e641`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39561351-glucagon-v1.json SHA-256: 9a8c5b98394ffa36aa8f2137c8c53296b19844a254b6f24ef8a24d5f34482cf6.